The Principals of Regis Medical
The Regis Medical team has been introducing new innovative technologies into Germany, Switzerland and the E.U. over the last 20 years.
Products were successfully introduced for the following companies:
- CoreValve, Inc., Irvine, U.S.A. (acquired by Medtronic, NYSE "MDT")
- InterVentional Technologies, Inc., Irvine, USA (acquired by Boston Scientific, NYSE "BSX")
- Embolic Protection, Inc., Menlo Park, USA (acquired by Boston Scientific, NYSE "BSX")
- ACIST Medical Systems, Inc., Minneapolis, USA (acquired by Bracco Group)
- MicroVena Corporation, Minneapolis, USA (acquired by ev3, Inc., Nasdaq "EVVV")
- Vascular Solutions, Inc., Minneapolis, USA (IPO on Nasdaq "VASC")
- Arterial Vascular Engineering, Santa Rosa, USA (acquired by Medtronic, NYSE "MDT")
- Endologix, Inc., Irvine, USA (IPO on Nasdaq under "ELGX")
Additionally, selective investments have been made in new technologies as follows:
- Micrus Endovascular Corp., San Jose, USA (IPO on Nasdaq under "MEND")
- Vascular Science, Inc., Minneapolis, USA (acquired by St. Jude Medical, NYSE "STJ")
Distribution companies created, built and exited successfully include the following:
- 1989 - 2002 Cardiologic GmbH (sold to Boston Scientific, NYSE "BSX")
- 1995 - 1999 MicroVena (Europa) GmbH (sold to MicroVena, Corp., Minneapolis, USA & later merged into ev3, Inc., Nasdaq "EVVV")
- 2003 - 2009 OVUM Ventures GmbH (sold to Medtronic, NYSE "MDT")